Award
Delivery Order #SPE2D326F6633
Fresenius Kabi Delivery Order for Diphenhydramine Vials under Indefinite Delivery Contract
Buyer
Defense Logistics Agency
Award Amount
$23.37
Ceiling
$23.37
Awarded
February 26, 2026
Period of Performance
Feb 26, 2026 – Feb 27, 2026
Identifier
SPE2D326F6633
NAICS
325411
This award represents a delivery order contract issued to Fresenius Kabi, LLC, a pharmaceutical company specializing in manufacturing critical medical supplies. The contract procures diphenhydramine 50 mg/ml vials, an essential medication used for various medical treatments, supporting the broader supply needs of the U.S. Department of Defense. The award is a component of an existing indefinite delivery contract that secures the ongoing provision of vital pharmaceutical products, underscoring its significance for military medical readiness and operational healthcare support. The work scope includes the timely manufacture and delivery of specific pharmaceutical vials to ensure medical preparedness. This order was awarded through a competitive process under an established contract vehicle, emphasizing a strategic approach to maintaining reliable access to medical supplies. The performance period is brief and specific, with delivery scheduled within a two-day timeframe. This delivery order aligns with previous contracts under the same indefinite delivery vehicle, reflecting a continued partnership to meet defense medical needs.
Description
4571056665!DIPHENHYDRAMINE 50 MG/ML VIALML